Recent advances indicate that chemoradiotherapy induces anti‐tumoural immunity by releasing tumour‐associated antigens and enhancing major histocompatibility complex (MHC) class I expression on tumour cells.9, 10, 11. This evidence concerns the gene HLA-C and neoplasm.